Insulin Aspart
- Product NDC
- 70518-2823
- 11-digit product format
- 705182823
- Labeler code
- 70518
- Product ID
- 70518-2823_e557ba60-cc95-a218-e053-2995a90af997
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- insulin aspart
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- REMEDYREPACK INC.
- Application
- BLA020986
- Marketing category
- BLA
- Marketing start
- 2020-08-03
- Marketing end
- 0000-00-00
- Substance
- INSULIN ASPART
- Active strength
- 100 [iU]/mL
- Pharmacologic classes
- Insulin Analog [EPC], Insulin [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-2823 | INSULIN ASPART INJECTION, SOLUTION [REMEDYREPACK INC.] | 5 | Legacy NDC | 20240308_8dddb455-b5f3-4317-a7ec-de90a0311ae3.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2823-0 | 70518282300 | 1 VIAL, GLASS in 1 CARTON (70518-2823-0) > 10 mL in 1 VIAL, GLASS | 2020-08-03 | 0000-00-00 | No | No | Current |